BioSpace News Archive

VYNE Therapeutics Inc. today announced the initiation of an investigator initiated trial (“IIT” or “study”) evaluating the safety and efficacy of AMZEEQ® (minocycline) topical foam, 4%, as a companion treatment with oral isotretinoin in patients with moderate to severe acne.

Aerovate Therapeutics, Inc. today announced the appointment of Allison Dorval, chief financial officer of Voyager Therapeutics, Inc. (“Voyager”), as a member of Aerovate’s Board of Directors.

New patent bolsters intellectual property protection for Firdapse® First in a family of four pending patents for Firdapse® to issue

Thermo Fisher Scientific today announced a new suite of Ion Torrent Oncomine immune repertoire assays designed to detect potentially malignant clones of T-cells and B-cells, which play a key role in the immune response system*

Imbria Pharmaceuticals today announced that the Hypertrophic Cardiomyopathy Center at Boston-based Tufts Medical Center has randomized the first patient in the IMPROVE-HCM study, a Phase 2 study

Allegro Ophthalmics , LLC today announced that the results of the company’s second ALG-1007 ex-U.S. clinical trial for the treatment of dry eye disease (DED) will be presented during the 2021 American Society of Cataract and Refractive Surgery and American Society of Ophthalmic Administrators (ASCRS ASOA) Annual Meeting being held July 23-27 in Las Vegas, NV.

Valneva SE, a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need, and Pfizer Inc., announced that they have completed recruitment for the Phase 2 trial, VLA15-221, of Lyme disease vaccine candidate, VLA15.

The global transcutaneous monitors market presents a large scope of opportunity and significant potential for investors during 2018-2028.

The increasing number of government funding and investments used for intense research and development activities for medical diagnostics is expected to boost the growth of the global single-cell analysis market during the forecast period 2020 to 2030.

Smart injury prevention and rehabilitation devices are type of smart medical devices. Smart medical devices are electronic devices with independent processing system.